According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Chronic Thromboembolic Pulmonary Hypertension Market

Chronic thromboembolic pulmonary hypertension is observed to be one of the leading causes of severe pulmonary hypertension. It is a type of clinical condition in which pulmonary vascular resistance increases giving rise to pulmonary hypertension and progressive heart failure. According to World Health Organization (WHO), approximately 0.15% to 0.55% of the patients suffering with acute pulmonary embolism develop chronic thromboembolic pulmonary hypertension. Due to non-specific symptoms observed in chronic thromboembolic pulmonary hypertension its diagnosis is complex. However, some of the prominent symptoms of chronic thromboembolic pulmonary hypertension are chest discomfort, breathlessness and fatigue. Chronic thromboembolic pulmonary hypertension market can be segmented on the basis of types of diagnosis such as transthoracic echocardiogram (TTE), ventilation-perfusion (V/Q) scan, pulmonary angiography, heart catheterization, computed tomography (CT) pulmonary angiography and other pulmonary function tests.

The global Chronic Thromboembolic Pulmonary Hypertension market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Chronic Thromboembolic Pulmonary Hypertension, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Thromboembolic Pulmonary Hypertension.

Report Scope

The Chronic Thromboembolic Pulmonary Hypertension market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Thromboembolic Pulmonary Hypertension market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Thromboembolic Pulmonary Hypertension companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Thromboembolic Pulmonary Hypertension Market Report

Report Metric	Details
Report Name	Chronic Thromboembolic Pulmonary Hypertension Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Transthoracic Echocardiogram (TTE) Ventilation-Perfusion (V/Q) Scan Pulmonary Angiography Heart Catheterization Computed Tomography (CT) Pulmonary Angiography Others
Segment by Application	Hospitals Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Johnson & Johnson, Nippon Shinyaku, GlaxoSmithKline, Sun Pharmaceutical Industries, Scipharm SaRL, Promedica International, Medical Research Network, Gilead Sciences, Daiichi Sankyo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Thromboembolic Pulmonary Hypertension companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Thromboembolic Pulmonary Hypertension Market report?

Ans: The main players in the Chronic Thromboembolic Pulmonary Hypertension Market are Bayer, Johnson & Johnson, Nippon Shinyaku, GlaxoSmithKline, Sun Pharmaceutical Industries, Scipharm SaRL, Promedica International, Medical Research Network, Gilead Sciences, Daiichi Sankyo

What are the Application segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

Ans: The Applications covered in the Chronic Thromboembolic Pulmonary Hypertension Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

Ans: The Types covered in the Chronic Thromboembolic Pulmonary Hypertension Market report are Transthoracic Echocardiogram (TTE), Ventilation-Perfusion (V/Q) Scan, Pulmonary Angiography, Heart Catheterization, Computed Tomography (CT) Pulmonary Angiography, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Transthoracic Echocardiogram (TTE)

1.2.3 Ventilation-Perfusion (V/Q) Scan

1.2.4 Pulmonary Angiography

1.2.5 Heart Catheterization

1.2.6 Computed Tomography (CT) Pulmonary Angiography

1.2.7 Others

1.3 Market by Application

1.3.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Perspective (2019-2030)

2.2 Chronic Thromboembolic Pulmonary Hypertension Growth Trends by Region

2.2.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Region (2019-2024)

2.2.3 Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Region (2025-2030)

2.3 Chronic Thromboembolic Pulmonary Hypertension Market Dynamics

2.3.1 Chronic Thromboembolic Pulmonary Hypertension Industry Trends

2.3.2 Chronic Thromboembolic Pulmonary Hypertension Market Drivers

2.3.3 Chronic Thromboembolic Pulmonary Hypertension Market Challenges

2.3.4 Chronic Thromboembolic Pulmonary Hypertension Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Revenue

3.1.1 Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Revenue (2019-2024)

3.1.2 Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Players (2019-2024)

3.2 Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Chronic Thromboembolic Pulmonary Hypertension Revenue

3.4 Global Chronic Thromboembolic Pulmonary Hypertension Market Concentration Ratio

3.4.1 Global Chronic Thromboembolic Pulmonary Hypertension Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Thromboembolic Pulmonary Hypertension Revenue in 2023

3.5 Chronic Thromboembolic Pulmonary Hypertension Key Players Head office and Area Served

3.6 Key Players Chronic Thromboembolic Pulmonary Hypertension Product Solution and Service

3.7 Date of Enter into Chronic Thromboembolic Pulmonary Hypertension Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Thromboembolic Pulmonary Hypertension Breakdown Data by Type

4.1 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Type (2019-2024)

4.2 Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2025-2030)

5 Chronic Thromboembolic Pulmonary Hypertension Breakdown Data by Application

5.1 Global Chronic Thromboembolic Pulmonary Hypertension Historic Market Size by Application (2019-2024)

5.2 Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Chronic Thromboembolic Pulmonary Hypertension Market Size (2019-2030)

6.2 North America Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024)

6.4 North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size (2019-2030)

7.2 Europe Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024)

7.4 Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size (2019-2030)

8.2 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2019-2024)

8.4 Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size (2019-2030)

9.2 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024)

9.4 Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size (2019-2030)

10.2 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024)

10.4 Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Detail

11.1.2 Bayer Business Overview

11.1.3 Bayer Chronic Thromboembolic Pulmonary Hypertension Introduction

11.1.4 Bayer Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.1.5 Bayer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Introduction

11.2.4 Johnson & Johnson Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Nippon Shinyaku

11.3.1 Nippon Shinyaku Company Detail

11.3.2 Nippon Shinyaku Business Overview

11.3.3 Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Introduction

11.3.4 Nippon Shinyaku Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.3.5 Nippon Shinyaku Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Detail

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Introduction

11.4.4 GlaxoSmithKline Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Development

11.5 Sun Pharmaceutical Industries

11.5.1 Sun Pharmaceutical Industries Company Detail

11.5.2 Sun Pharmaceutical Industries Business Overview

11.5.3 Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Introduction

11.5.4 Sun Pharmaceutical Industries Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.5.5 Sun Pharmaceutical Industries Recent Development

11.6 Scipharm SaRL

11.6.1 Scipharm SaRL Company Detail

11.6.2 Scipharm SaRL Business Overview

11.6.3 Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Introduction

11.6.4 Scipharm SaRL Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.6.5 Scipharm SaRL Recent Development

11.7 Promedica International

11.7.1 Promedica International Company Detail

11.7.2 Promedica International Business Overview

11.7.3 Promedica International Chronic Thromboembolic Pulmonary Hypertension Introduction

11.7.4 Promedica International Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.7.5 Promedica International Recent Development

11.8 Medical Research Network

11.8.1 Medical Research Network Company Detail

11.8.2 Medical Research Network Business Overview

11.8.3 Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Introduction

11.8.4 Medical Research Network Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.8.5 Medical Research Network Recent Development

11.9 Gilead Sciences

11.9.1 Gilead Sciences Company Detail

11.9.2 Gilead Sciences Business Overview

11.9.3 Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Introduction

11.9.4 Gilead Sciences Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.9.5 Gilead Sciences Recent Development

11.10 Daiichi Sankyo

11.10.1 Daiichi Sankyo Company Detail

11.10.2 Daiichi Sankyo Business Overview

11.10.3 Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Introduction

11.10.4 Daiichi Sankyo Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

11.10.5 Daiichi Sankyo Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sun Pharmaceutical Industries

SciPharm SaRL

Promedica International

Medical Research Network

Gilead Sciences

Daiichi Sankyo

List of Tables

Table 1. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Transthoracic Echocardiogram (TTE)

Table 3. Key Players of Ventilation-Perfusion (V/Q) Scan

Table 4. Key Players of Pulmonary Angiography

Table 5. Key Players of Heart Catheterization

Table 6. Key Players of Computed Tomography (CT) Pulmonary Angiography

Table 7. Key Players of Others

Table 8. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2019-2024)

Table 12. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2025-2030)

Table 14. Chronic Thromboembolic Pulmonary Hypertension Market Trends

Table 15. Chronic Thromboembolic Pulmonary Hypertension Market Drivers

Table 16. Chronic Thromboembolic Pulmonary Hypertension Market Challenges

Table 17. Chronic Thromboembolic Pulmonary Hypertension Market Restraints

Table 18. Global Chronic Thromboembolic Pulmonary Hypertension Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Players (2019-2024)

Table 20. Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2023)

Table 21. Ranking of Global Top Chronic Thromboembolic Pulmonary Hypertension Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Chronic Thromboembolic Pulmonary Hypertension Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Chronic Thromboembolic Pulmonary Hypertension Product Solution and Service

Table 25. Date of Enter into Chronic Thromboembolic Pulmonary Hypertension Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2019-2024)

Table 29. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Type (2025-2030)

Table 31. Global Chronic Thromboembolic Pulmonary Hypertension Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Application (2019-2024)

Table 33. Global Chronic Thromboembolic Pulmonary Hypertension Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Chronic Thromboembolic Pulmonary Hypertension Revenue Market Share by Application (2025-2030)

Table 35. North America Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size by Country (2025-2030) & (US$ Million)

Table 50. Bayer Company Detail

Table 51. Bayer Business Overview

Table 52. Bayer Chronic Thromboembolic Pulmonary Hypertension Product

Table 53. Bayer Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 54. Bayer Recent Development

Table 55. Johnson & Johnson Company Detail

Table 56. Johnson & Johnson Business Overview

Table 57. Johnson & Johnson Chronic Thromboembolic Pulmonary Hypertension Product

Table 58. Johnson & Johnson Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 59. Johnson & Johnson Recent Development

Table 60. Nippon Shinyaku Company Detail

Table 61. Nippon Shinyaku Business Overview

Table 62. Nippon Shinyaku Chronic Thromboembolic Pulmonary Hypertension Product

Table 63. Nippon Shinyaku Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 64. Nippon Shinyaku Recent Development

Table 65. GlaxoSmithKline Company Detail

Table 66. GlaxoSmithKline Business Overview

Table 67. GlaxoSmithKline Chronic Thromboembolic Pulmonary Hypertension Product

Table 68. GlaxoSmithKline Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 69. GlaxoSmithKline Recent Development

Table 70. Sun Pharmaceutical Industries Company Detail

Table 71. Sun Pharmaceutical Industries Business Overview

Table 72. Sun Pharmaceutical Industries Chronic Thromboembolic Pulmonary Hypertension Product

Table 73. Sun Pharmaceutical Industries Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 74. Sun Pharmaceutical Industries Recent Development

Table 75. Scipharm SaRL Company Detail

Table 76. Scipharm SaRL Business Overview

Table 77. Scipharm SaRL Chronic Thromboembolic Pulmonary Hypertension Product

Table 78. Scipharm SaRL Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 79. Scipharm SaRL Recent Development

Table 80. Promedica International Company Detail

Table 81. Promedica International Business Overview

Table 82. Promedica International Chronic Thromboembolic Pulmonary Hypertension Product

Table 83. Promedica International Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 84. Promedica International Recent Development

Table 85. Medical Research Network Company Detail

Table 86. Medical Research Network Business Overview

Table 87. Medical Research Network Chronic Thromboembolic Pulmonary Hypertension Product

Table 88. Medical Research Network Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 89. Medical Research Network Recent Development

Table 90. Gilead Sciences Company Detail

Table 91. Gilead Sciences Business Overview

Table 92. Gilead Sciences Chronic Thromboembolic Pulmonary Hypertension Product

Table 93. Gilead Sciences Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 94. Gilead Sciences Recent Development

Table 95. Daiichi Sankyo Company Detail

Table 96. Daiichi Sankyo Business Overview

Table 97. Daiichi Sankyo Chronic Thromboembolic Pulmonary Hypertension Product

Table 98. Daiichi Sankyo Revenue in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024) & (US$ Million)

Table 99. Daiichi Sankyo Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Type: 2023 VS 2030

Figure 3. Transthoracic Echocardiogram (TTE) Features

Figure 4. Ventilation-Perfusion (V/Q) Scan Features

Figure 5. Pulmonary Angiography Features

Figure 6. Heart Catheterization Features

Figure 7. Computed Tomography (CT) Pulmonary Angiography Features

Figure 8. Others Features

Figure 9. Global Chronic Thromboembolic Pulmonary Hypertension Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Ambulatory Surgical Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Chronic Thromboembolic Pulmonary Hypertension Report Years Considered

Figure 15. Global Chronic Thromboembolic Pulmonary Hypertension Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Chronic Thromboembolic Pulmonary Hypertension Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Region: 2023 VS 2030

Figure 18. Global Chronic Thromboembolic Pulmonary Hypertension Market Share by Players in 2023

Figure 19. Global Top Chronic Thromboembolic Pulmonary Hypertension Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Thromboembolic Pulmonary Hypertension as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Chronic Thromboembolic Pulmonary Hypertension Revenue in 2023

Figure 21. North America Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)

Figure 23. United States Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)

Figure 27. Germany Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Chronic Thromboembolic Pulmonary Hypertension Market Share by Region (2019-2030)

Figure 35. China Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)

Figure 43. Mexico Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Chronic Thromboembolic Pulmonary Hypertension Market Share by Country (2019-2030)

Figure 47. Turkey Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Chronic Thromboembolic Pulmonary Hypertension Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Bayer Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 50. Johnson & Johnson Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 51. Nippon Shinyaku Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 52. GlaxoSmithKline Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 53. Sun Pharmaceutical Industries Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 54. Scipharm SaRL Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 55. Promedica International Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 56. Medical Research Network Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 57. Gilead Sciences Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 58. Daiichi Sankyo Revenue Growth Rate in Chronic Thromboembolic Pulmonary Hypertension Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-2P14533

Thu May 02 00:00:00 UTC 2024

Add to Cart

Synthetic Fiber Vascular Prosthesis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-38F13932

Thu May 02 00:00:00 UTC 2024

Add to Cart

Rapamycin Target Eluting Stent System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-33P14399

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Intracranial Thrombus Aspiration Catheter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-2Z14762

Tue Apr 30 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-13N6290

Global Chronic Thromboembolic Pulmonary Hypertension Market Research Report 2024

FEATURED COMPANIES

Chronic Thromboembolic Pulmonary Hypertension Market Size

Chronic Thromboembolic Pulmonary Hypertension Market

Report Scope

Scope of Chronic Thromboembolic Pulmonary Hypertension Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Chronic Thromboembolic Pulmonary Hypertension Market report?

What are the Application segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

What are the Type segmentation covered in the Chronic Thromboembolic Pulmonary Hypertension Market report?

FEATURED COMPANIES

RELATED REPORTS